Integrating Care: The Role of MOUD in Addressing Opioid Use Disorder and Infectious Disease

Sponsor: Providers Clinical Support System

Due to the opioid epidemic, over 2.5 million adults in the U.S. have opioid use disorder (OUD), yet only 25% of those who need treatment receive recommended medication for opioid use disorder (MOUD). Alongside the rising rates of OUD, there has been an increase in infectious diseases such as HIV, hepatitis B and C, endocarditis and skin and soft-tissue infections, particularly among people who inject drugs. These intertwining epidemics have not been sufficiently addressed, but MOUD — combined with appropriate substance use treatment supports and health care services — represents an opportunity to reduce risk and improve health outcomes.

Join the Providers Clinical Support System (PCSS) MOUD and the National Council for Mental Wellbeing on Wednesday, Jan. 29, 1-2 p.m. ET, as we discuss these public health crises and the role that integrated opioid use disorder (OUD) and infectious disease care can play in reducing risk and improving health outcomes. Attendees will learn from expert medical professionals about the latest evidence-based practices for OUD and

For more information and to register click here

Event Details